Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. Liesl De Graeve from Gent, company number BE1004593663, closed financial year 2025 with a result of € -6,763 after tax. For that financial year Dr. Liesl De Graeve recorded a gross margin of € 7,009 and equity of € -5,617. Compared with financial year 2024, the result moved from € -2,354 to € -6,763. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ -5,617
▼ € 6,763 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6,763
▼ 187 % more loss than in 2024
Profit after tax over the fiscal year.
€ 2,738
▼ 38% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -9,117.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 35,155
▼ 18% vs 2024
Of which on lease € 33,176.
Debts at end 2025
€ 35,952
▼ 17% vs 2024
€ 7,952 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 831
Supplier invoices still open on the last day of the fiscal year.
€ 153
▼ 7% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 5,222 | € 7,009 | ▲ 34% |
| Profit after taxes | € -2,354 | € -6,763 | ▼ € 4,409 |
| Equity | € 1,146 | € -5,617 | ▼ € 6,763 |
| Total debts | € 51,085 | € 47,152 | ▼ 8% |
| Cash | € 4,405 | € 2,738 | ▼ 38% |
| Retained profit | € -2,354 | € -9,117 | ▼ € 6,763 |
| Bank debt | € 43,540 | € 35,952 | ▼ 17% |
| Balance sheet total | € 52,231 | € 41,535 | ▼ 20% |
Key figures of Dr. Liesl De Graeve, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Liesl De Graeve?
What happened at Dr. Liesl De Graeve in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6,763. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Gent. KBO
- Liesl De Graeve became a director. NBB
In short
From € 2,354 loss in 2024 to € 6,763 loss in 2025.
Paid € 242 in corporate taxes since 2024.
Management
Behind Dr. Liesl De Graeve is Liesl De Graeve.
Directors
According to the 2025 annual accounts
Liesl De Graeve
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Elfjulistraat 136
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- De Graeve, Liesl(oprichter) 100%
Details
- Company number
- 1004.593.663
- VAT number
- BE 1004.593.663
- Registered office
- Elfjulistraat 136, 9000 Gent
- Names & denominations
- Dr. Liesl De Graeve
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2024
- Peppol
- Active · Active since 1 Jul 2025
- Activities · NACE
Activiteiten van medisch specialisten